The problem of choice: current biologic agents and future prospects in RA
- 19 February 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 9 (3), 154-163
- https://doi.org/10.1038/nrrheum.2013.8
Abstract
The introduction of biologic agents to clinical practice has had a major bearing on the treatment of patients with chronic inflammatory diseases such as rheumatoid arthritis. These drugs have the potential to improve the outcome of disease and the quality of life for patients. However, clinical criteria alone are inadequate for determining which therapy is most appropriate for an individual patient. Furthermore, why a particular drug is effective in a particular patient, or indeed in any patient, but is ineffective for other individuals, is often unknown. In this Review, we provide an overview of biologic therapies currently available for patients with rheumatoid arthritis, and discuss why certain immunological regulators represent potential targets for intervention. Current agents can be clustered into three major types: cytokine blockers, lymphocyte-targeting agents, and small-molecule inhibitors of signal transduction pathways. We differentiate among the modes of action of each of these types of therapy and consider the challenges associated with their use in clinical practice.This publication has 89 references indexed in Scilit:
- Predictors for remission in rheumatoid arthritis patients: A systematic reviewArthritis Care & Research, 2010
- Effector T cell plasticity: flexibility in the face of changing circumstancesNature Immunology, 2010
- Epigenetic Instability of Cytokine and Transcription Factor Gene Loci Underlies Plasticity of the T Helper 17 Cell LineageImmunity, 2010
- CD4+ T Cell Plasticity—Th2 Cells Join the CrowdImmunity, 2010
- Cytokine/Jak/Stat Signaling Mediates Regeneration and Homeostasis in the Drosophila MidgutCell, 2009
- Rheumatoid arthritisLancet, 2009
- Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity in Lineage Fate Determination of Differentiating CD4+ T CellsImmunity, 2009
- Late Developmental Plasticity in the T Helper 17 LineageImmunity, 2009
- Cytokine Signaling Modules in Inflammatory ResponsesImmunity, 2008
- Cytokines in the pathogenesis of rheumatoid arthritisNature Reviews Immunology, 2007